Intrinsic Value of S&P & Nasdaq Contact Us

WPD Pharmaceuticals Inc. WPDPF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score
38/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

WPD Pharmaceuticals Inc. (WPDPF) is a Biotechnology company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 35/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Net income is $80,082 (loss), growing at +30.6%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $303,898 with negative equity of -$555,958 — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.2 (tight liquidity). Debt-to-assets is 87.7%. Total assets: $346,407.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 100/100 (Pass), Past 25/100 (Fail), Health 0/100 (Fail), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

WPDPF SharesGrow Score Overview

51/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.00003-0.001
Volume10K
Avg Volume (30D)4.4K
Market Cap$140.00
Beta (1Y)0.14
Share Statistics
EPS (TTM)0.00
Shares Outstanding$113.59M
IPO Date2020-01-13
Employees16
CEOMariusz Olejniczak
Financial Highlights & Ratios
EBITDA$-233.23K
Net Income$-80.08K
Operating Income$-268.91K
Total Cash$85.86K
Total Debt$303.9K
Net Debt$218.04K
Total Assets$346.41K
Price / Earnings (P/E)-0
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA92941F2044

Price Chart

WPDPF
WPD Pharmaceuticals Inc.  ·  Other OTC
Healthcare • Biotechnology
0.00 52WK RANGE 0.00
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message